Filing Flows

Filing Flows › Ocular Therapeutix (OCUL) › How it makes money

How Ocular Therapeutix (OCUL) makes money

Ocular Therapeutix (OCUL) made $13.5M of revenue in the second quarter 2026 (Q2 2026), +0.1% from a year earlier.

Drawing the Sankey…

Ocular Therapeutix: revenue by line, Q4 2024 to Q2 2025Ocular Therapeutix: revenue by line, Q4 2024 to Q2 2025Product revenue, netCollaboration revenueProduct revenue, net: $13.4M latest$13.4MCollaboration revenue: $64K latestQ4 2024Q1 2025Q2 2025
The mix barely moved between Q4 2024 and Q2 2025.
Ocular Therapeutix revenue by quarterOcular Therapeutix revenue by quarter$17.1MQ4 2024$10.7MQ1 2025$13.5MQ2 2025$14.5MQ3 2025$13.2MQ4 2025$10.8MQ1 2026$13.5MQ2 2026

Where each dollar of revenue goes

LineQ2 2026% of revenue
Revenue$13.5M100.0%

Revenue, quarter by quarter

QuarterRevenueY/Y
Q2 2026$13.5M+0.1%
Q1 2026$10.8M+0.8%
Q4 2025$13.2M-22%
Q3 2025$14.5M-6%
Q2 2025$13.5M-18%
Q1 2025$10.7M-28%
Q4 2024$17.1M+15%

From Ocular Therapeutix's 10-Q filed Aug 3, 2026 (on EDGAR).

Questions

How does Ocular Therapeutix make money?

Ocular Therapeutix (OCUL) made $13.5M of revenue in the second quarter 2026 (Q2 2026), +0.1% from a year earlier.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.